IPIX - Innovation Pharmaceuticals Inc.

Discussion in 'Penny Stocks' started by Allegiance, Apr 7, 2016.

  1. Jim BooDog

    Jim BooDog Active Member

    Joined:
    Apr 7, 2016
    Messages:
    150
    Likes Received:
    40
    The Company’s common stock will continue to trade under stock symbol “CTIX” on OTCQB until market close on June 8, 2017. Trading on the OTCQB under the new Innovation Pharmaceuticals name and ticker symbol “IPIX” will begin at market open on June 9, 2017.

    The Company’s new website address will change to www.IPharmInc.com. In the interim, the Company will maintain www.cellceutix.com.

    Will need to update the name for the thread and stock symbol as well.
     
    Ciao (Sheppy) likes this.
  2. Ciao (Sheppy)

    Ciao (Sheppy) Well-Known Member

    Joined:
    Apr 4, 2016
    Messages:
    4,002
    Likes Received:
    617
    at last you finish with CTIX...... same thing but at least different name ;):D
     
    Jim BooDog likes this.
  3. Jim BooDog

    Jim BooDog Active Member

    Joined:
    Apr 7, 2016
    Messages:
    150
    Likes Received:
    40
  4. Allegiance

    Allegiance Member

    Joined:
    Apr 5, 2016
    Messages:
    46
    Likes Received:
    8
    IPIX / CTIX finally moving a little bit in anticipation of B-OM results within the next week.
     
  5. Jonathan Wiley

    Joined:
    Jun 13, 2017
    Messages:
    46
    Likes Received:
    7
  6. Allegiance

    Allegiance Member

    Joined:
    Apr 5, 2016
    Messages:
    46
    Likes Received:
    8
    The only thing that will get this company out of the gutter is partnership news. Hopefully 2018 brings that. They have some very promising drug candidates in mid-late stage trials and a solid trial history. I'm hopeful, but years of stagnant or declining SP has been disheartening. I first invested in CTIX when I was a new investor. Knowing what I know now, I would not have at the time.

    I said the word 'hope' a lot, that tells you all you need to know about CTIX/IPIX as an investment.
     
  7. Edson wag

    Edson wag Member

    Joined:
    Apr 6, 2016
    Messages:
    105
    Likes Received:
    9
    Yesterday, the company provided additional perspectives on the planned continued development of Brilacidin-OM for the prevention and treatment of Oral Mucositis (OM) in Head and Neck Cancer (HNC) patients. The Phase 2 randomized, placebo-controlled clinical trial of Brilacidin-OM, enrolling a total of 61 patients, recently was completed,.
     

Share This Page